Furudate A, Hirose S, Abe K, Kawashima A, Hashimoto K, Yamazaki S, Kamei K, Ishiwada
N, Hamada H, Sato M: Infantile Aspergillus fumigatus ventriculitis successfully
treated with monitoring of plasma and cerebrospinal fluid voriconazole concentration
level. J Infect Chemother. 2020 Jan;26(1):132-135. doi:
10.1016/j.jiac.2019.06.011.
Arai S, Ishikawa T, Kato H, Koshizaka M, Maezawa Y, Nakamura T, Suzuki T, Yokote K,
Ishii I: Multidrug use positively correlates with high-risk prescriptions in the
Japanese elderly: a longitudinal study. J Pharm Health Care Sci. 2019 Sep
2;5:20. doi: 10.1186/s40780-019-0150-6.
Lazarova D, Shibata S, Ishii I, Zlateva G, Zhelev Z, Aoki I, Bakalova R: Imaging of
redox-imbalance and oxidative stress in kidney in vivo, induced by dietary
cholesterol. Biotechnol. Biotechnol. Equip. doi:
10.1080/13102818.2019.1573153.
Lazarova D, Shibata S, Ishii I, Zlateva G, Zhelev Z, Aoki I, Higashi T, Bakalova R:
Nitroxide-enhanced magnetic resonance imaging of kidney dysfunction in vivo based on
redox-imbalance and oxidative stress. Gen Physiol Biophys. 2019;38:191-204.
Igari H, Yamagishi K, Yamazaki S, Murata S, Yahaba M, Takayanagi S, Kawasaki Y,
Taniguchi T: Epidemiology and treatment outcome of pneumonia: Analysis based on
Japan national database. J Infect Chemother. 2020 Jan;26(1):58-62. doi:
10.1016/j.jiac.2019.07.001.
Izumi-Nakaseko H, Fujiyoshi M, Hagiwara-Nagasawa M, Goto A, Chiba K, Kambayashi R,
Naitou AT, Ando K, Kanda Y, Ishii I, Sugiyama A: Dasatinib can Impair Left
Ventricular Mechanical Function But May Lack Proarrhythmic Effect: A Proposal of
Non‑clinical Guidance for Predicting Clinical Cardiovascular Adverse Events of
Tyrosine Kinase Inhibitors. Cardiovasc Toxicol. 2019. doi:
10.1007/s12012-019-09538-5.
Ishikawa M, Yamazaki S, Suzuki T, Uchida M, Iwadate Y, Ishii I: Correlation between
vancomycin penetration into cerebrospinal fluid and protein concentration in
cerebrospinal fluid/serum albumin ratio. J Infect Chemother.
2019;25(2):124-128.
Yamazaki K, Ariyoshi N, Miyauchi H, Ohira G, Kaneya N, Yamamoto K, Arai K, Yamazaki
S, Matsubara H, Suzuki T, Ishii I: A randomized controlled, open-label early phase
II trial comparing incidence of FOLFIRI.3-induced diarrhea between Hangeshashinto
and oral alkalization in Japanese patients with colorectal cancer. J Clin Pharm
Ther. 2019 Dec;44(6):946-951.
Takachi T, Arakawa Y, Nakamura H, Watanabe T, Aoki Y, Ohshima J, Takahashi Y,
Hirayama M, Miyamura T, Sugita K, Koh K, Horibe K, Ishii E, Mizutani S, Tomizawa D:
Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic
stem cell transplantation in infants with acute lymphoblastic leukemia. Int J
Hematol. 2019 Sep;110(3):355-363.
Suzuki T, Suzuki T, Takatsuka H, Yamazaki S, Ishii I: Successful treatment of
seizure disorder by evaluating phenobarbital clearance in a paediatric patient
undergoing continuous haemodiafiltration. J Clin Pharm Ther.
2019;44(3):479-481.
Hiromi Kaneko, Kiyoshi Shikino, Takako Nakamura, Takaaki Suzuki, Masatomi Ikusaka,
Itsuko Ishii: Differences between physicians and pharmacists in the clinical
reasoning process to adverse drug reactions, 79th FIP World Congress of Pharmacy and
Pharmaceutical Sciences, アブダビ(2019.9.22-26).
